Abstract

Purpose
To explore the perceived and potential roles of pharmacists in the care of young people aged 10-24 years with chronic illness, through the exemplar of juvenile arthritis, from the perspectives of UK community and hospital pharmacists, health service commissioners, rheumatology health professionals and lay advocates.
Methods
A sequential mixed methods study design comprising: focus groups with community and hospital pharmacists; telephone interviews with pharmacy and rheumatology stakeholders and commissioners, and multidisciplinary group discussions to prioritize roles generated by the first two qualitative phases.
Results
The high priority roles for pharmacists, identified by pharmacists and rheumatology staff, were: developing generic healthcare skills among young people; transferring information effectively across care interfaces; building trusting relationships with young people; helping young people to find credible online health information, and the need to develop specialist expertise. Participants identified associated challenges for pharmacists in supporting young people with chronic illness.
These challenges included parents collecting prescription refills alone, thus reducing opportunities to engage, and pharmacist isolation from the wider healthcare team.
Conclusions
This study has led to the identification of specific enhancements to pharmacy services for young people which have received the endorsement of a wide range of stakeholders. These suggestions could inform the next steps in developing the contribution of community and hospital pharmacy to support young people with chronic illness in the optimal use of their medication.
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Implications and Contribution
The role of community/retail and hospital pharmacists in the care of young people with chronic illness could be further developed to complement the role of other healthcare providers. Research in this area has been scarce. Priority roles, and associated challenges, are identified by stakeholders within and beyond pharmacy.
The role of pharmacists in caring for young people with chronic illness 6 The role of the pharmacist as a member of the adolescent health team, particularly in the care of young people with chronic illness, has not been widely researched. The two main employment groups are community pharmacists (sometimes called 'retail pharmacists') and hospital pharmacists. In this paper, there will be reference to 'pharmacists' as a professional group across the two settings; in some places it will be necessary to differentiate between the two environments. There are good reasons to consider the engagement of pharmacists in adolescent medication use. In developed countries, transcending the way that health systems and medication supply are financed, the vast majority of prescriptions for medication for young people will have been reviewed, checked and/or dispensed by a pharmacist. Woods et al. 1 undertook secondary analysis of adolescent data from a large medical care dataset in Colorado and Utah. Medicationrelated events were the second most frequent source of safety problems, and the highest incidence of patient safety issues occurred in the pharmacy setting.
The role of the community pharmacist in reproductive and public health has attracted more research. Emergency contraception studies noted that young women have found the profession to compare well to other reproductive health providers -accessibility and non-judgmental attitude were positively cited 2 , and 94% of adolescents said they would recommend the service to a friend 3 . Studies have also, however, highlighted the potential for community pharmacists to break confidentiality -when, for example, pharmacists might contact a parent before dispensing contraception to minors 4 . In relation to vaccination, there has been recognition of the potential of the community pharmacy setting as a 'unique resource' to increase adolescent immunization rates 5 -but the need to increase pharmacists' experience with young people was noted.
Pharmacists report a lack of training and confidence in engaging with young people 4 .
Community pharmacy staff are unsure whether their adult-focused services should be offered to young people, especially those aged under 16 years 6 . UK pharmacists may, however, be gaining confidence from providing public health services to young people. In a small study, almost twothirds (62.2%) of the 143 community pharmacists surveyed felt 'reasonably confident' about engaging with young people, and almost another third (30.1%) felt 'very confident' 7 . Increasing numbers of community pharmacists internationally now provide commissioned services to discuss medication with patients. The most commonly used overarching term to describe these cognitive, patient-centered services that go beyond the supply function is 'pharmaceutical care' 8 , but other country-specific terms include 'medication therapy management' (US) and 'medicines optimization' (England). A study of UK community pharmacists reported significant selfreported engagement with young people 7 . Whilst approximately half of these pharmacists reported dispensing prescriptions 'often' and providing public health services 'often' for young people aged 13-19 years (53.8% and 45.4% respectively), only 5.2% reported chronic medication review activities 'often' with this age group.
The aim of this study was to explore the perceived and potential roles of pharmacists in the care of young people with chronic illness, through the exemplar of juvenile arthritis, from the perspectives of UK community and hospital pharmacists, rheumatology health professionals and health service commissioners (payers).
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The WHO age range for young people of 10-24 years was adopted in this research in order to reflect the range of important biological, cognitive, psychosocial and vocational transitions that can impact on the use of medication 9 .
Methods
An overview of the project methods is provided in Table 1 . A blog-based project called 'Arthriting' was undertaken by the authors in 2012/13 to elicit the views of young people attending a rheumatology service aged 11-19 years, and their parents/caregivers, about the links between identity, the arthritis condition and medication [10] [11] [12] . This subsequent project would challenge pharmacists with the 'Arthriting' data to think how they could better engage with, and support, young people with chronic illness and their families.
The sequential mixed methods study design 13 allowed stakeholders to identify, and then prioritize, current and future roles that would underpin the pharmacist's contribution to the care of young people with chronic illness. The first two phases -pharmacist focus groups and stakeholder telephone interviews -were qualitative, reflecting the dearth of literature in this area and the need to capture and record ideas from pharmacists and stakeholders about current and future roles that would support young people and families. The final phase -multidisciplinary discussion groups -was quantitative, encouraging pharmacists and rheumatology professionals to discriminate between ideas and to prioritize roles to be developed or enhanced. Each phase had a particular objective within the aim of the overall study.
Institutional ethical approval for the study was given by Aston University Health and Life Sciences Research Ethics Committee.
Recruitment of Participants
A number of recruitment strategies were employed to recruit pharmacists to Phases 1 and 3, through gatekeepers in the Royal Pharmaceutical Society (RPS) -the national professional body for pharmacy, the national continuing education organizations in England and Wales, and the NHS regions surrounding the group venue in Scotland. The RPS does not represent all pharmacists -during the recruitment period 54% of all licensed pharmacists in Great Britain were members. It is, however, the national professional forum and that was deemed appropriate for recruiting pharmacists for this work. The continuing education organization and NHS mailing lists, however, do include most registered community and hospital pharmacists. We aimed for maximum diversity sampling to reflect different pharmacist characteristics in terms of length of time in practice, role in practice and practice setting. Administrators sent out an initial email asking for expressions of interest. Interested pharmacists were asked to reply direct to the project manager (NJG). An article was placed in the 'Pharmaceutical Journal', which was the weekly professional publication sent to all members of the Royal Pharmaceutical Society. The inclusion criterion was to be a practicing community or hospital pharmacist who could travel to the group venue on the advertised date -there were no exclusion criteria.
A list of stakeholders for telephone interviews in Phase 2 was generated by advisory group members and the project team. Inclusion criteria were participation at a senior level in a pharmacy or rheumatology organization. An email was sent to each suggested stakeholder, including an outline of the interview study and an invitation to reply if they would like more information; one follow-up email was sent 7 days later. The study was also advertised by email to all members of the Barbara Ansell National Network for Adolescent Rheumatology (BANNAR) http://bannar.org.uk/ . BANNAR includes the majority of adolescent/young adult focused rheumatologists in the UK, including both pediatric and adult multidisciplinary rheumatology professionals.
To recruit rheumatology staff in Phase 3 an email was sent to a facilitator in each of three hospital pediatric rheumatology centers for whom we had a contact among the project team and/or advisory group members. There are 15 similar training centers across the UK; the population served by these centers reflected their local communities well. The multidisciplinary rheumatology team members invited included doctors, clinical nurse specialists, occupational therapists, physiotherapists and transition coordinators. Again we aimed for maximum diversity within the targeted team to include different roles and length of experience.
All phases involved obtaining informed written consent from participants. All participants were offered a modest honorarium for their contribution. Travel expenses were offered in Phases 1 and 3. Locum backfill payments were offered to community pharmacists for Phase 3 as the groups were conducted during pharmacy opening hours.
Research Settings
Phase 1 pharmacist focus groups were convened in the evening, scheduled for 90 minutes. The venues were also used for local pharmacy group meetings, thus familiar to participants. All four focus groups were facilitated by the project manager (NJG).
Phase 3 multidisciplinary discussion groups were convened at the targeted pediatric rheumatology centers across England and Scotland, and scheduled during a time dedicated to a regular weekly continuing medical education session for the multidisciplinary team. Hospital pharmacists, who would not normally have been included in those sessions, joined the rheumatology team from their base on-site. Community pharmacists travelled to the center to join the session.
Discussion and Interview guides
The Phase 1 topic guide included pharmacists' experience of engaging with young people about medication use and adherence; pharmacists' experience of engaging with specialist teams in hospital, including rheumatology, and their perception of current and future roles in the care of young people with chronic illnesses.
Phase 2 stakeholders were sent a briefing before the interview to give them background information and prompts which would guide the interview. It combined 'Arthriting' blog quotes, some innovative pharmacist case studies, and an interim analysis of the Phase 1 focus groups.
The telephone interview schedule was tailored to the role of the interviewee, including rheumatology team members' experience of engaging with hospital and/or community pharmacists about young people (positive or negative), and commissioners'/payers' views about pharmacists' potential to support young people taking medication.
A quantitative approach was applied to the Phase 3 discussions, adopting techniques of prioritization and sorting deployed in nominal groups 14 . A consensus-building tool for a previous study 15 was adapted to provide a structured format for paper-based prioritization exercises. Small multidisciplinary groups of 2-3 people undertook a paper-based exercise where they assigned a ranking (1-5, where 1 is low) to current or potential pharmacy roles.
Pharmacists and rheumatology staff attending the Phase 1 and 3 groups noted their demographic details on a structured pro-forma, before the session began, to help the team to monitor diversity.
Data Analysis
Data analysis in this project was dynamic, as each phase built upon the previous one to prioritize best practice development roles for pharmacists to better support young people and families.
Qualitative Data Analysis (Phases 1 and 2)
Phase 1 focus group discussions and Phase 2 telephone interviews were recorded on digital audio, which were transcribed verbatim, checked, and identifiers (names of people or places)
were removed. A 'middle-order' thematic approach 16 was used, which is consistent with 'directed content analysis' 17 . The study objectives provided a source of categories with which to organize participants' responses, whilst allowing other themes to emerge. 
Quantitative Data Analysis (Phase 3)
Phase 3 data were transcribed from paper data collection forms to an Excel™ spreadsheet. The analysis of data from the final discussion groups was basic descriptive statistical analysis of quantitative ranking (tables of frequencies). The mean rank for the score achieved for each pharmacy role was calculated.
Triangulation
Triangulation of data took place at two key milestones during the study. At the end of Phase 2, the data from both qualitative phases were compared to finalize the possible roles that would be incorporated into the Phase 3 prioritization materials. Following the analysis of the quantitative Phase 3 prioritization data, we returned to the qualitative data to provide context and illustration for the themes corresponding to the highest priority roles. Table 1 describes the participants in this study. There was diversity of setting, experience and role among pharmacists in the study. The focus groups took place in two large cities, one small city with rural outskirts and one small town. In Phase 1 focus groups, for example, the 9 community pharmacists reported their main settings as village (n=5), suburban high street (n=3) and local neighborhood shops (n=1). The 7 hospital pharmacists who provided data on their hospital type classified them as large (n=4), medium (n=1) and small (n=2). Three of the 9 participating hospital pharmacists were not based in pediatric institutions. Roles ranged from newly qualified pharmacists in their first managerial role through to chief pharmacists of large teaching hospitals.
Results
[ Table 1 goes about here]
In Phase 3 there was similar diversity of setting and experience among the pharmacy attendees.
Rheumatology staff provided multidisciplinary input from physicians, nurses and a physiotherapist. Inevitably these specialist centers were based in three large cities, but community pharmacists travelled in from surrounding suburban and village settings to take part. Table 2 reports the prioritization of pharmacy roles by Phase 3 participants, which represent the study priorities for community pharmacy service development.
[ 
Discussion
This study identified a diverse range of potential opportunities, and clear priorities, to guide service developments to support pharmaceutical care for young people with chronic illness. The
The role of pharmacists in caring for young people with chronic illness 19 high priority roles identified by pharmacists and rheumatology staff were: developing generic healthcare skills among young people; transferring information across care interfaces; building trusting relationships with young people; helping young people to find credible online health information, and the need to develop specialist expertise. The support offered must be sensitive to the multiple physical, emotional and social transitions experienced by young people aged 10-24, tailored to each individual.
It is relatively easy to develop pharmacy public health roles because the activities can be exercised independently of other professionals; a role in chronic illness management cannot be exercised in isolation. For juvenile arthritis, the rheumatology team may include doctors, nurses, physiotherapists, occupational therapists and transition-focused personnel. Primary care doctors will also play a role. A review of the case notes of 150 young people aged 11-18 attending the rheumatology service at a large UK pediatric hospital showed that pharmacy involvement was not being recorded 19 . The blog-based 'Arthriting' study revealed few references to pharmacists among the accounts from young people and parents 10 . Moreover, during the 'Arthriting' research, a scoping review of the literature was undertaken to determine the contribution of pharmacists to the care of young people with three exemplar chronic illnesses (juvenile arthritis, insulin-dependent diabetes mellitus IDDM and inflammatory bowel disease IBD) 10 . There was only one account of a pharmacist-directed peer support program for six young people with IDDM in the USA 20 -pharmacy initiatives are not widespread for this age group.
Juvenile arthritis has a prevalence similar to type I diabetes, affecting 1 in 1,000 children and young people in the UK 21 with active disease that continues for a significant number into condition will have its own features and challenges, chronic illnesses have common characteristics 22 . Community pharmacists are generalists, and many hospital pharmacists have to operate across a number of clinical specialties, so this 'non-categorical' approach 23 can enable the profession to engage with generic chronic illness issues during adolescence. All pharmacists must, however, possess enough specialist knowledge to ensure medication use is safe for all
patients. There are a number of medication-related issues that particularly concern young people, such as interactions with alcohol and other drugs, and side-effects 24 . Pharmacists will need to recognize these issues and be ready to offer relevant advice about medication dispensed for young people. We would expect the principles of young people friendly services 25 to apply across chronic illnesses, and that young people's priorities regarding services -and the nature of their consultations with pharmacists -are also likely to be similar. It therefore seems reasonable to take insights from juvenile arthritis to inform the pharmacy contribution to the care of young people with a wide range of chronic illnesses.
Young people may be more open to using the pharmacist as a health information channel than adults. A 2014 survey of 4,182 consumers across France, Germany, Portugal and the UK reported that respondents aged 24 and younger were more likely than other age groups to consider pharmacists a trustworthy source of information 26 . Many young people are very engaged in self-management in the home, but withdraw when they are in a medical setting 27 ; pharmacists based in a familiar retail setting may be able to recognize and foster the partnerships between young people and parents. They could also have a role in supporting young people through transition, as a constant and accessible source of advice when other services are
The role of pharmacists in caring for young people with chronic illness 21 changing. Recent work in the UK has confirmed that the 'You're Welcome' youth-friendly service criteria can be applied directly to the community pharmacy setting 28 . To realize these aspirations, the training of pharmacists will have to include resources about providing developmentally appropriate care to young people, including physical and cognitive development.
This project was successful in engaging a broad range of participants across the UK. The present project was built on the findings from the previous 'Arthriting' study 10 , using 'Arthriting' data - Consensual prioritization of roles to inform study recommendations 
4.78
Information supplied by hospital pharmacists at discharge goes directly to a nominated community pharmacist as well as the GP. Pharmacists develop specialist expertise in pediatric/adolescent rheumatology.
4.44
Pharmacists develop specialist expertise in young people's medication use for other longterm conditions (asthma, diabetes).
Pharmacists provide educational sessions for the multidisciplinary rheumatology team about medicines optimization.
b
Community pharmacists can support young people and families in medication-taking.
4.33
Pharmacists facilitate young people's self-advocacy skills (e.g. decision-making, effective communication, disclosure).
b
Hospital pharmacists can build long-term relationships with young people and families. 4.14 b
Hospital pharmacists do continuing professional development sessions for community pharmacists about JIA medicines.
4.11
Pharmacists support transition services for young people going into adult rheumatology care. Pharmacists need to develop better skills in confidentiality and consent for young people.
3.22
Pharmacists need to develop better skills in safeguarding for young people.
3.11
Community pharmacists co-ordinate supply of JIA medication for young people.
2.89
Hospital pharmacists do clinics in the community for young people with JIA.
2.22
Priority mean scores are reported to 2 decimal places -data averaged from 9 multidisciplinary groups. a = 8 groups; b = 7 groups -some groups did not complete ranking for all roles.
